Nitric oxide in health and disease of the respiratory system

Physiological Reviews

Volumn 84, Issue 3, 2004, Pages 731-765

  Ricciardolo, Fabio L M ^a   Sterk, Peter J ^a   Gaston, Benjamin ^a   Folkerts, Gert ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ARGINASE INHIBITOR; ARGININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRATE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; OXIDIZING AGENT; PEROXYNITRITE; REACTIVE NITROGEN SPECIES; S NITROSOTHIOL; STEROID; UNCLASSIFIED DRUG;

AIRWAY DYNAMICS; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; BRONCHUS TONE; CELL TYPE; CHRONIC INFLAMMATION; CONCENTRATION RESPONSE; EXHALATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOMODULATION; INFLAMMATION; NEUROMODULATION; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PNEUMONIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY FUNCTION; RESPIRATORY TRACT DISEASE; REVIEW; SIDE EFFECT;

ADMINISTRATION, INHALATION; ANIMALS; ASTHMA; EXHALATION; HEALTH; HUMANS; NITRIC OXIDE; OXIDATIVE STRESS; RESPIRATION DISORDERS; RESPIRATORY PHYSIOLOGY; RESPIRATORY SYSTEM;

EID: 2342482002     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.00034.2003     Document Type: Review

References (470)

1. Ca channel in airway smooth muscle by nitric oxide: involvement of a nitrothiosylation mechanism? Am J Respir Cell Mol Biol 19: 485-497, 1998.
2. Adcock IM, Brown CR, Kwon O, and Barnes PJ. Oxidative stress NF kappa B DNA binding and inducible NOS mRNA in human epithelial cells. Biochem Biophys Res Commun 199: 1518-1524, 1994.
3. Adler KB, Fischer BM, Li H, Choe NH, and Wright DT. Hypersecretion of mucin in response to inflammatory mediators by guinea pig tracheal epithelial cells in vitro is blocked by inhibition of nitric oxide synthase. Am J Respir Cell Mol Biol 13: 526-530, 1995.
4. Adnot S, Raffestin B, Eddamibi S, Braquet P, and Chabrier PE. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest 87: 155-162, 1991.
5. Agusti AG, Villaverde JM, Togores B, and Bosch M. Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease. Eur Respir J 14: 523-528, 1999.
6. Ahren C, Jungersten L, and Sandberg T. Plasma nitrate as an index of nitric oxide formation in patients with acute infectious diseases. Scand J Infect Dis 31: 405-407, 1999.
7. Aimi Y, Fujimura M, Vincent SR, and Kimura H. Localization of NADPH-diaphorase-containing neurons in sensory ganglia of the rat. J Comp Neurol 306: 382-392, 1991.
8. Aizawa H, Takata S, Inoue H, Matsumoto K, Koto H, and Hara N. Role of nitric oxide released from iNANC neurons in airway responsiveness in cats. Eur Respir J 13: 775-780, 1999.
9. Ali S, Metzger WJ, Olanrewaju HA, and Mustafa SJ. Adenosine receptor-mediated relaxation of rabbit airway smooth muscle: a role for nitric oxide. Am J Physiol Lung Cell Mol Physiol 273: L581-L587, 1997.
10. Allione A, Bernabei P, Bosticardo M, Ariotti S, Forni G, and Novelli F. Nitric oxide suppresses human T lymphocyte proliferation through IFN-γ-dependent and IFN-γ-independent induction of apoptosis. J Immunol 178: 102-108, 1999.
11. Alving K, Fornhem C, and Lundberg JM. Pulmonary effects of endogenous and exogenous nitric oxide in the pig: relation to cigarette smoke inhalation. Br J Pharmacol 110: 739-746, 1993.
12. Alving K, Weitzberg E, and Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 6: 1368-1370, 1993.
13. American Thoracic Society. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. Am J Respir Crit Care Med 160: 2104-2117, 1999.
14. Andersson C, Gaston B, and Roomans G. S-Nitrosoglutathione induces functional ΔF508 CFTR in cultured airway epithelial cells. Biochem Biophys Res Commun 297: 552-557, 2002.
15. Arias-Diaz J, Vara E, Torres-Melero J, Garcia C, Baki W, Ramirez-Armengol JA, and Balibrea JL. Nitrite/nitrate and cytokine levels in bronchoalveolar lavage fluid of lung cancer patients. Cancer 74: 1546-1551, 1994.
16. Asano K, Chee CBE, Gaston B, Lilly CM, Gerard C, Drazen JM, and Stamler JS. Constitutive and inducible nitric oxide synthase gene expression, regulation and activity in human lung epithelial cells. Proc Natl Acad Sci USA 91: 10089-10093, 1994.
17. Asikainen TM, Raivio KO, Saksela M, and Kinnula VL. Expression and development profile of antioxidant enzymes in human lung and liver. Am J Respir Cell Mol Biol 19: 942-949, 1998.
18. Askew S, Butler A, Flitney F, Kemp G, and Megson I. Chemical mechanisms underlying the vasodilator and platelet anti-aggregating properties of S-nitroso-N-acetyl-dl-penicillamine and S-nitrosoglutathione. Biorganic Med Chem 3: 1-9, 1995.
19. Aviado DM, Folle LE, and Bellet S. Cardiopulmonary effects of glyceryl trinitrate and isosorbide dinitrate. Cardiology 52: 287-303, 1968.
20. Babior AM. Oxygen-dependent microbial killing by phagocytes (two parts). N Engl J Med 298: 659-668/721-725, 1978.
21. Babior BM. NADPH-oxidase: an update. Blood 93: 1464-1476, 1999.
22. Babior BM, Kipnes RS, and Curnutte JT. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 52: 741-744, 1973.
23. Baile EM, McKay K, Wang L, Bai TR, and Parè PD. NO does not mediate inhibitory neural responses in sheep airway and bronchial vascular smooth muscle. J Appl Physiol 84: 809-814, 1998.
24. Bannenberg G, Xue J, Engman L, Cotgreave I, Moldéus P, and Ryrfeldt A. Characterization of bronchodilator effects and fate of S-nitrosothiols in the isolated perfused and ventilated guinea pig lung. J Pharmacol Exp Ther 272: 1238-1245, 1995.
25. Baraldi Dario C, Ongaro R, Scollo M, Azzolin NM, Panza N, Paganini N, and Zacchello FE. Exhaled nitric oxide concentrations during treatment of wheezing exacerbation in infants and young children. Am J Respir Crit Care Med 159: 1284-1288, 1999.
26. Baraldi E, de Jongste JC, on behalf of the ERS/ATS Task Force. Measurement of exhaled nitric oxide in children. Eur Respir J 20: 223-237, 2002.
27. Barnes PJ and Belvisi MG. Nitric oxide and lung disease. Thorax 48: 1034-1043, 1993.
28. Barnes PJ and Liew FY. Nitric oxide and asthmatic inflammation. Immunol Today 16: 128-130, 1995.
29. Bates CA and Silkoff PE. Exhaled nitrix oxide in asthma: from bench to bedside. J Allergy Clin Immunol 111: 256-262, 2003.
30. Beall CM, Laskowski D, Strohl KP, Soria R, Villena M, Vargas E, Alarcon AM, Gonzales C, and Erzurum SC. Pulmonary nitric oxide in mountain dwellers. Nature 414: 411-412, 2001.
31. Belvisi MG, Stretton CD, and Barnes PJ. Nitric oxide modulates cholinergic neurotransmission in guinea-pig tracheal smooth muscle. Eur J Pharmacol 198: 219-222, 1991.
32. Belvisi MG, Stretton CD, Yacoub M, and Barnes PJ. Nitric oxide is the endogenous neurotransmitter of bronchidilator nerves in humans. Eur J Pharmacol 210: 221-222, 1992.
33. Bernareggi M, Mitchell JA, Barnes PJ, and Belvisi MG. Dual action of nitric oxide on airway plasma leakage. Am J Respir Crit Care Med 155: 869-874, 1997.
34. Black PN and Brodie SM. Nitric oxide and response to inhaled bradykinin in severe asthma. Lancet 351: 449-450, 1998.
35. Blackford JA, Antonini JMJ, Castranova V, and Dey RD. Intratracheal instillation of silica up-regulates inducible nitric oxide synthase gene expression and increases nitric oxide production in alveolar macrophages and neutrophils. Am J Respir Crit Care Med 11: 426-431, 1994.
36. Boucher JL, Moali C, and Tenu JP. Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization. Cell Mol Life Sci 55: 1015-1028, 1999.
37. Bowler RP and Crapo JD. Oxidative stress in allergic respiratory diseases. J Allergy Clin Immunol 110: 349-356, 2002.
38. Bozza M, Bliss JL, Dorner AJ, and Trepicchio WL. Interleukin-II modulates TH1/Th2 cytokine production from activated CD4+ T cells. J Interferon Cytokine Res 21: 21-30, 2001.
39. Bredt DS, Hwang PM, and Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347: 768-770, 1990.
40. Bredt DS and Snyder SH. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 86: 9030-9033, 1989.
41. Bredt DS and Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87: 682-685, 1990.
42. 1-syntrophin mediated by PDZ domains. Cell 84: 757-767, 1996.
43. Brockhaus F and Brune B. U937 apoptotic cell death by nitric oxide: Bcl-2 downregulation and caspase activation. Exp Cell Res 238: 33-41, 1998.
44. Budts W, Poskreisz P, Nong Z, van Pelt N, Gillijns H, Gerard R, Lyons R, Collen D, Block KD, and Janssens S. Aerosol gene transfer with inducible nitric oxide synthase reduces hypoxic pulmonary hypertension and pulmonary vascular remodelling in rats. Circulation 102: 2880-2885, 2000.
45. G-hydroxy-L-arginine during high-output NO production. Am J Physiol Heart Circ Physiol 271: H1988-H1998, 1996.
46. Bult H, Boeckxstaens GE, Pelckmans PA, Jordaens FH, Van Maercke YM, and Herman AG. Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter. Nature 345: 346-347, 1990.
47. Bush A. Primary ciliary diskinesia. Acta Otorhinolaryngol Belg 54: 317-324, 2000.
48. Buttery LD, Evans TJ, Springall DR, Carpenter A, Cohen J, and Polak JM. Immunochemical localization of inducible nitric oxide synthase in endotoxin-treated rats. Lab Invest 71: 755-764, 1994.
49. Byrick RJ, Hobbs EG, Martineau R, and Noble WH. Nitroglycerin relaxes large airways. Anesth Anal 62: 421-425, 1983.
50. Canning BJ and Fischer A. Neural regulation of airway smooth muscle tone. Respir Physiol 125: 113-127, 2001.
51. Canning BJ, Fischer A, and Undem BJ. Pharmacological analysis of the tachykinin receptors that mediate activation of nonadrenergic, noncholinergic relaxant nerves that innervate guinea pig trachealis. J Pharmacol Exp Ther 284: 370-377, 1998.
52. Canning BJ and Undem BJ. Evidence that distinct neural pathways mediate parasympathetic contractions and relaxations of guinea-pig trachealis. J Physiol 471: 25-40, 1993.
53. Cantin AM, Fells GA, Hubbard RC, and Crystal RG. Antioxidant macromolecules in the epithelial lining fluid of the normal human lower respiratory tract. J Clin Invest 86: 962-971, 1990.
54. Cantin AM, North SL, Hubbard RC, and Crystal RG. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol 63: 152-157, 1987.
55. Carvajal JA, Germain AM, Huidobro-Toro JP, and Weiner CP. Molecular mechanism of cGMP-mediated smooth muscle relaxation. J Cell Physiol 184: 409-420, 2000.
56. Champion HC, Bivalacqua TJ, Greenberg SS, Giles TD, Hyman AL, and Kadowitz PJ. Adenoviral gene transfer of endothelial nitric-oxide synthase (eNOS) partially restores normal pulmonary arterial pressure in eNOS-deficient mice. Proc Natl Acad Sci USA 99: 13248-13253, 2002.
57. Chan J, Xing Y, Magliozzi S, and Bloom BR. Killing of virulent Mycobacterium tubercolosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 175: 1111-1122, 1992.
58. Chang RH, Feng MH, Liu WH, and Lai MZ. Nitric oxide increased interleukin-4 expression in T lymphocytes. Immunology 90: 364-369, 1997.
59. Charan NB, Johnson S, Lakshminarayan S, Thompson WH, and Carvalho P. Nitric oxide and β-adrenergic agonist-induced bronchial arterial vasodilation. J Appl Physiol 82: 686-692, 1997.
60. Clark RH, Huckaby JL, Kueser TJ, Walker MW, Southgate WM, Perez JA, Roy BJ, and Keszler M. Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up. J Perinatol 23: 300-303, 2003.
61. Clini E, Bianchi L, Pagani M, and Ambrosino N. Endogenous nitric oxide in patients with stable COPD: correlates with severity of disease. Thorax 53: 881-883, 1998.
62. Clini E, Cremona G, Campana M, Scotti C, Pagani M, Bianchi L, Giordano A, and Ambrosino N. Production of endogenous nitric oxide in chronic obstructive pulmonary disease and patients with cor pulmonale. Correlates with echo-doppler assessment. Am J Respir Crit Care Med 162: 446-450, 2000.
63. Cockcroft DW, Ruffin RW, Dolovich J, and Hargreave FE. Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy 7: 503-513, 1977.
64. Coers W, Timens W, Kempinga C, Klok PA, and Moshage H. Specificity of antibodies to nitric oxide synthase isoforms in human, guinea pig, rat, and mouse tissues. J Histochem Cytochem 46: 1385-1392, 1998.
65. Cooper CJ, Landzberg MJ, Anderson TJ, Charbonneau F, Creager MA, Ganz P, and Selwyn AP. Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans. Circulation 93: 266-271, 1996.
66. Corradi M, Majori M, Cacciani GC, Consigli GF, de Munari E, and Pesci A. Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease. Thorax 54: 572-575, 1999.
67. Cremona G, Dinh-Xuan AT, and Higenbottam T. Endothelium-derived relaxing factor and the pulmonary circulation. Lung 169: 185-202, 1991.
68. Culotta E and Koshland DE Jr. NO news is good news. Science 258: 1862-1865, 1992.
69. De Boer J, Duyvendak M, Schuurman FE, Pouw FMH, Zaagsma J, and Meurs H. Role of L-arginine in the deficiency of nitric oxide and airway hyperreactivity after the allergen-induced early asthmatic reaction in guinea-pigs. Br J Pharmaeol 128: 1114-1120, 1999.
70. De Boer J, Meurs H, Coers W, Koopal M, Bottone AE, Visser AC, Timens W, and Zaagsma J. Deficiency of nitric oxide in allergen-induced airway hyperreactivity to contractile agonists after the early asthmatic reaction: an ex vivo study. Br J Pharmacol 119: 1109-1116, 1996.
71. De Gouw HWFM, Grünberg K, Schot R, Kroes LCM, Dick EC, and Sterk PJ. Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects. Eur Respir J 11: 126-132, 1998.
72. Delelaux C, Mahut B, Zerah-Lancner F, Delacourt C, Lauod S, Cherqui D, Duvoux C, Mallat A, and Harf A. Increased nitric oxide output from alveolar origin during liver cirrhosis versus bronchial source during asthma. Am J Respir Crit Care Med 165: 332-337, 2002,
73. Denis M. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell Immunol 131: 150-157, 1991.
74. De Sanctis GT, MacLean JA, Hamada K, Mehta S, Scott JA, Jiao A, Yandava CN, Kobzik L, Wolyniec WW, Fabian AJ, Venugopal CS, Grasemann H, Huang PL, and Drazen JM. Contribution of nitric oxide synthase 1, 2 and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma. J Exp Med 189: 1621-1629, 1999.
75. De Sanctis GT, Mehta S, Kobzik L, Yandava C, Jiao A, Huang PL, and Drazen JM. Contribution of type I NOS to expired gas NO and bronchial responsiveness in mice. Am J Physiol Lung Cell Mol Physiol 273: L883-L888, 1997.
76. Deves R and Boyd CA. Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol Rev 78: 487-545, 1998.
77. Dey RD, Mayer B, and Said SI. Colocalization of vasoactive intestinal peptide and nitric oxide synthase in neurons of the ferret trachea. Neuroscience 54: 839-843, 1993.
78. Diaz de RO, Villaro AC, Montuenga LM, Martinez A, Springall DR, and Polak JM. Nitric oxide synthase-immunoreactive neurons in the human and porcine respiratory tract. Neurosci Lett 162: 121-124, 1993.
79. Dinh-Xuan AT, Higenbottam TW, Clelland CA, Pepke-Zaba J, Cremona G, Butt AY, Large SR, Wells FC, and Wallwork J. Impairment of endothelium-dependent pulmonary artery relaxation in chronic obstructive lung disease. N Engl J Med 324: 1539-1547, 1991.
80. Dotsch J, Demirakca S, Terbrack HG, Huls G, Rascer W, and Kuhl PG. Airway nitric oxide in asthmatic children and patients with cystic fibrosis. Eur Respir J 9: 2537-2540, 1996.
81. Downey D and Elborn JS. Nitric oxide, iNOS, and inflammation in cystic fibrosis. J Pathol 190: 115-116, 2000.
82. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, and Kurzchalia TV. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293: 2449-2452, 2001.
83. Droma Y, Hanaoka M, Ota M, Katsuyama Y, Koizumi T, Fujimoto K, Kobayashi T, and Kubo K. Positive association of the endothelial nitric oxide synthase gene polymorphisms with high-altitude pulmonary edema. Circulation 106: 826-830, 2002.
84. Dupont LJ, Rochette F, Demedts MG, and Verleden GM. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma. Am J Respir Crit Care Med 157: 894-898, 1998.
85. Dupuy PM, Shore SA, Drazen JM, Frostell C, Hill WA, and Zapol WM. Bronchodilator action of inhaled nitric oxide in guinea pigs. J Clin Invest 90: 421-428, 1992.
86. Duszyk M. Regulation of anion secretion by nitric oxide in human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 281: IA50-IA57, 2001.
87. Duszyk M and Radomski MW. The role of nitric oxide in the regulation of ion channels in airway epithelium: implications for diseases of the lung. Free Radical Res 33: 449-459, 2000.
88. Dweik R, Comhair S, Gaston B, Thunnissen F, Farver C, Thomassen M, Kavaru M, Hammel J, Abu-Soud H, and Erzurum S. Nitric oxide chemical events in the human airway during the immediate and late antigen-induced asthmatic response. Proc Natl Acad Sci USA 98: 2622-2627, 2001.
89. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, and Van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils, Nature 391: 393-397, 1998.
90. Eiserich JP, Patel RP, and O'Donnell VB. Pathophysiology of nitric oxide and related species: free radical reactions and modification of biomolecules. Mol Aspects Med 19: 221-357, 1998.
91. Ellis JL and Undem BJ. Antigen-induced enhancement of non-cholinergic contractile responses to vagus nerve and electrical field stimulation in guinea pig isolated trachea. J Pharmacol 262: 646-653, 1992.
92. G-nitro-L-arginine of nonadrenergic-noncholinergic-mediated relaxations of human isolated central and peripheral airways. Am Rev Respir Dis 146: 1543-1547, 1992b.
93. Emanueli C, Ricciardolo FLM, Vergnani L, Bertrand C, Fellin R, Folkerts G, Nijkamp FP, and Geppetti P. Characterization of the endothelin receptor subtypes mediating relaxant NO release from guinea pig trachea. Br J Pharmacol 125: 963-968, 1998,
94. Erjefalt JS, Erjefalt I, Sundler F, and Persson CG. Mucosal nitric oxide may tonically suppress plasma exudation. Am J Respir Crit Care Med 150: 227-232, 1994.
95. Ermert M, Ruppert C, Gunther A, Duncker HR, Seeger W, and Ermert L. Cell-specific nitric oxide synthase-isoenzyme expression and regulation in response to endotoxin in intact rat lungs. Lab Invest 82: 425-441, 2002.
96. Exner R, Wessner B, Manhart N, and Roth E. Therapeutic potential of glutathione. Wien Klin Wochenschr 112: 610-616, 2000.
97. Fang FC. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 99: 2818-2825, 1997.
98. Fang FC and Vazquez-Torres A. Nitric oxide production by human macrophages: there's NO doubt about it. Am J Physiol Lung Cell Mol Physiol 282: L941-L943, 2002.
99. Fang K, Johns R, MacDonald T, Kinter M, and Gaston B. S-Nitrosoglutathione breakdown prevents airway smooth muscle relaxation in the guinea pig. Am J Physiol Lung Cell Mol Physiol 279: L716-L721, 2000.
100. Feletou M, Lonchampt M, Coge F, Galizzi J-P, Bassoullet C, Merial C, Robineau P, Boutin JA, Huang PL, Vanhoutte PM, and Canet E. Regulation of murine airway responsiveness by endothelial nitric oxide synthase. Am J Physiol Lung Cell Mol Physiol 281: L258-L267, 2001.
101. Figini M, Emanueli C, Bertrand C, Javdan P, and Geppetti P. Evidence that tachykinins relax the guinea-pig trachea via nitric oxide release and by stimulation of a septide-insensitive NK1 receptor. Br J Pharmacol 117: 1270-1276, 1996.
102. Figini M, Ricciardolo FLM, Javdan P, Nijkamp F, Ernanueli C, Pradeless P, Folkerts G, and Geppetti P. Evidence that epithelium-derived relaxing factor released by bradykinin in guinea-pig trachea is nitric oxide. Am J Respir Crit Care Med 153: 918-923, 1996.
103. Filep JG, Battistini B, and Sirois P. Induction by endothelin-1 of epithelium-dependent relaxation of guinea-pig trachea in vitro: role for nitric oxide. Br J Pharmacol 109: 637-644, 1993.
104. Fischer A, Canning BJ, Undem BJ, and Kummer W. Evidence for an esophageal origin of VIP-IR and NO synthase-IR nerves innervating the guinea pig trachealis: a retrograde neuronal tracing and immunohistochemical analysis. J Comp Neurol 394: 326-334, 1998.
105. Fischer A, Folkerts G, Geppetti P, and Groneberg DA. Mediators of asthma: nitric oxide. Pulm Pharmacol Ther 15: 73-81, 2002.
106. Fischer A and Hoffmann B. Nitric oxide synthase in neurons and nerve fibers of lower airways and in vagal sensory ganglia of man. Am J Respir Crit Care Med 154: 209-216, 1996.
107. Fischer A, Mayer B, and Kummer W. Nitric oxide synthase in vagal sensory and sympathetic neurons innervating the guinea-pig trachea. J Auton Nerv Syst 56: 157-160, 1996.
108. Fischer A, Mundel P, Mayer B, Preissler U, Phillipin B, and Kummer W. Nitric oxide synthase in guinea pig lower airway innervation. Neurosci Lett 149: 157-160, 1993.
109. Folkerts G, Busse WW, Nijkamp FP, Sorkness R, and Gern JE. Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med 157: 1708-1720, 1998.
110. Folkerts G, Kloek J, Muijsers RBR, and Nijkamp FP. Reactive nitrogen and oxygen species in airway inflammation. Eur J Pharmacol 429: 251-262, 2001.
111. Folkerts G and Nijkamp F. Airway epithelium: more than just a barrier! Trends Pharmacol Sci 19: 334-341, 1998.
112. Folkerts G, van der Linde, and Nijkamp FP. Virus-induced airway hyperresponsiveness in guinea pigs is related to a deficiency in nitric oxide. J Clin Invest 94: 26-30, 1995.
113. Ford PC, Wink DA, and Stanbury DM. Autoxidation kinetics of aqueous nitric oxide. FEBS Lett 326: 1-3, 1993.
114. Förstermann U, Boissel J-P, and Kleinert H. Expressional control of the "constitutive" isoforms of nitric oxide synthase (NOS I and ENOS). FASEB J 12: 773-790, 1998.
115. Förstermann U, Pollock JS, Schmidt HH, Heller M, and Murad F. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc Natl Acad Sci USA 88: 1788-1792, 1991.
116. Förstermann U, Schmidt HH, Pollock JS, Sheng H, Mitchell JA, Warner TD, Nakane M, and Murad F. Isoforms of nitric oxide synthase: characterization and purification from different cell types. Biochem Pharmacol 42: 1849-1857, 1991.
117. Fortenberry JD, Owens ML, and Brown LA. S-nitrosoglutathione enhances neutrophil DNA fragmentation and cell death. Am J Physiol Cell Physiol 276: C435-C442, 1999.
118. Fratacci MD, Frostell C, Chen T-Y, Wain JC, Robinson DR, and Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology 75: 990-999, 1991.
119. Fredberg JJ. Frozen objects: small airways, big breaths, and asthma. J Allergy Clin Immunol 162: 615-624, 2000.
120. -. Methods Enzymol 105: 59-61, 1984.
121. Frostell C, Fratacci M-D, Wain JC, Jones R, and Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83: 2038-2047, 1991.
122. Fujimoto H, Ando Y, Yamashita T, Terazaki H, Tanaka Y, Sasaki J, Matsumoto M, Suga M, and Ando M. Nitric oxide synthase activity in human lung cancer. Jpn J Cancer Res 88: 1190-1198, 1997.
123. Fujimoto H, Sasaki J, Matsumoto M, Suga M, Ando Y, Iggo R, Tada M, Saya H, and Ando M. Significant correlation of nitric oxide synthase activity and p53 gene mutation in stage I lung adenocarcinoma. Jpn J Cancer Res 89: 696-702, 1998.
124. Furchgott RF and Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
125. Gaston B. Nitric oxide and thiol groups. Biochim Biophys Acta 1411: 323-333, 1999.
126. Gaston B, Drazen J, Chee CBE, Wohl MEB, and Stamler JS. Expired nitric oxide (NOx) concentrations are elevated in patients with reactive airways disease (Abstract). Endothelium 1: S87, 1993.
127. Gaston B, Drazen JM, Jansen A, Sugarbaker DA, Loscalzo J, Richards W, and Stamler JS. Relaxation of human bronchial smooth muscle by S-nitrosothiols in vitro. J Pharmacol Exp Ther 268: 978-984, 1994.
128. Gaston B, Drazen JM, Loscalzo J, and Stamler JS. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 149: 538-551, 1994.
129. Gaston B, Kobzik L, and Stamler JS. Distribution of nitric oxide synthase in the lung. In: Nitric Oxide and the Lung, edited by W. M. Zapol and K. D. Bloch. New York: Dekker, 1997, p. 75-86.
130. Gaston B, Massaro A, Drazen J, Chee CBE, Wohl MEB, and Stamler JS. Expired nitric oxide levels are elevated in patients with asthma. In: Biology of Nitric Oxide, edited by S. Moncada, M. Feelisch, R. Busse, and E. A. Hibbs. London: Portland, 1994, vol. 3, p. 497-499.
131. Gaston B, Ratjen F, Vaughan JW, Malhotra NR, Canady RG, Snyder AH, Hunt JF, Gaertig S, and Goldberg JB. Nitrogen redox balance in the cystic fibrosis airway: effects of anti-pseudomonal therapy. Am J Respir Crit Care Med 165: 387-390, 2002.
132. Gaston B, Reilly J, Drazen JM, Fackler J, Ramden P, Arnelle D, Mullins ME, Sugarbaker D, Chea C, Singel D, Loscalzo J, and Stamler JS. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci USA 90: 10957-10961, 1993.
133. Gaston B, Sears S, Woods J, Hunt J, Ponaman M, McMahon T, and Stamler JS. Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure. Lancet 351: 1317-1319, 1998.
134. Genaro A, Hortelano S, Alvarez A, Martínez AC, and Boscá L. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J Clin Invest 95: 1884-1890, 1995.
135. Germann P, Ziesche R, Leitner C, Roeder G, Urak G, Zimpfer M, and Sladen R. Addition of nitric oxide to oxygen improves cardiopulmonary function in patients with severe COPD. Chest 114: 29-35, 1998.
136. Giaid A and Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 333: 214-221, 1995.
137. Gibson PG, Henry RL, and Thomas P. Noninvasive assessment of airway inflammation in children: induced sputum, exhaled nitric oxide, and breath condensate. Eur Respir J 16: 1008-1015, 2000.
138. Gibson QH and Roughton FJW. The kinetics of equilibria of the reactions of nitric oxide with sheep hemoglobin. J Physiol 136: 507-526, 1957.
139. Gilchrist M, Savoie M, Nohara O, Wills FL, Wallace JL, and Befus AD. Nitric oxide synthase and nitric oxide production in in vivo-derived mast cells. J Leukoc Biol 71: 618-624, 2002.
140. Goldman D, Cho Y, Zhao M, Casadevall A, and Lee SC. Expression of inducible nitric oxide synthase in rat pulmonary cryptococcus neoformans granulomas. Am J Pathol 148: 1275-1282, 1996.
141. - · toward NADH. Chem Res Toxicol 13: 736-741, 2000.
142. Gonzales RJ, Walker BR, and Kanagy NL. 17β-Estradiol increases nitric oxide-dependent dilation in rat pulmonary arteries and thoracic aorta. Am J Physiol Lung Cell Mol Physiol 280: L555-L564, 2001.
143. Goodman LS and Gilman A. The Pharmacological Basis of Therapeutics. Philadelphia, PA: Lea & Febiger, 1936, p. 631.
144. Gow AJ, Chen Q, Hess DT, Day BJ, Ischiropoulos H, and Stamler JS. Basal and stimulated protein S-nitrosylation in multiple cell types and tissues. J Biol Chem 277: 9637-9640, 2002.
145. Gow AJ and Stamler JS. Reactions between nitric oxide and haemoglobin under physiological conditions. Nature 391: 169-173, 1998.
146. Grasemann H, Gaston B, Fang K, Paul K, and Ratjen F. Decreased levels of nitrosothiols in the lower airways of patients with cystic fibrosis and normal pulmonary function. JPediatr 135: 770-772, 1999.
147. Grasemann H, Michler E, Wallot M, and Ratjen F. Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis. Pediatr Pulmonol 24: 173-177, 1997.
148. Gratziou C, Lignos M, Dassiou M, and Roussos C. Influence of atopy on exhaled nitric oxide in patients with stable asthma and rhinitis. Eur Respir J 14: 897-901, 1999.
149. Green SJ, Meltzer MS, Hibbs JB Jr, and Nacy CA. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J Immunol 144: 278-283, 1990.
150. Griffith MJ, Liu S, Curzen NP, Messent M, and Evans TW. In vivo treatment with endotoxin induces nitric oxide synthase in rat main pulmonary artery. Am J Physiol Lung Cell Mol Physiol 268: L509-L518, 1995.
151. Gruetter CA, Childers CE, Bosserman MK, Lemke SM, Ball JG, and Valentovic MA. Comparison of relaxation induced by glyceryl trinitrate, isosorbide dinitrate, and sodium nitroprusside in bovine airways. Am Rev Respir Dis 139: 1192-1197, 1989.
152. Guembe L and Villaro AC. Histochemical demonstration of neuronal nitric oxide synthase during development of mouse respiratory tract. Am J Respir Cell Mol Biol 20: 342-345, 1999.
153. Guo FH, Comhair SAA, Zheng S, Dweik RA, Eissa NT, Thomassen MJ, Calhoun W, and Erzurum SC. Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis. J Immunol 164: 5970-5980, 2000.
154. Guo FH, DeRaeve HR, Rice TW, Stuehr DJ, Thunnissen FB, and Erzurum SC. Contiuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci USA 92: 7809-7813, 1995.
155. Guo FH, Uetani K, Haque SJ, Williams BR, Dweik RA, Thunnissen FB, Calhoun W, and Erzurum SC. Interferon γ and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators. J Clin Invest 100: 829-838, 1997.
156. Gustafsson LE, Leone AM, Persson MG, Wiklund NP, and Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 18: 852-857, 1991.
157. Haddad EB, Liu SF, Salmon M, Robichaud A, Barnes PJ, and Chung KF. Expression of inducible nitric oxide synthase mRNA in Brown Norway rats exposed to ozone: effect of dexamethasone. Eur J Pharmacol 293: 287-290, 1995.
158. Haendeler J, Hoffman J, Tischler V, Berk B, Zeiher A, and Dimmeler S. Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. Nature Cell Biol 4: 743-749, 2002.
159. Halbower AC, Tuder RM, Franklin WA, Pollack JS, Forstermann U, and Abman SH. Maturation-related changes in endothelial nitric oxide synthase immunolocalization in developing ovine lung. Am J Physiol Lung Cell Mol Physiol 267: L585-L591, 1994.
160. Hamad AM, Johnson SR, and Knox AJ. Antiproliferative effects of NO and ANP in cultured human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 277: L910-L918, 1999.
161. Hamad AM and Knox AJ. Mechanisms mediating the antiproliferative effects of nitric oxide in cultured human airway smooth muscle cells. FEBS Lett 506: 91-96, 2001.
162. Hamid Q, Springall DR, Riveros-Moreno V, Chanez P, Howarth P, Redington A, Bousquet J, Godard P, Holgate S, and Polak JM. Induction of nitric oxide synthase in asthma. Lancet 342: 1510-1513, 1993.
163. Hansel TT, Kharitonov SA, Donnely LE, Erin EM, Currie MG, Moore WM, Manning PT, Recker DP, and Barnes PJ. A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics. FASEB J 17: 1298-1300, 2003.
164. Haque SJ and Williams BRG. Signal transduction in the interferon system. Semin Oncol 25: 14-22, 1998.
165. Haraguchi Y, Takiguchi M, Amaya Y, Kawamoto S, Matsuda I, and Mori M. Molecular cloning and nucleotide sequence of cDNA for human liver arginase. Proc Natl Acad Sci USA 84: 412-415, 1987.
166. G-hydroxy-L-arginine in alveolar macrophages: implications for the utilization of L-arginine for nitric oxide synthesis. FEBS Lett 359: 251-254, 1995.
167. Henricks PAJ, Verhoef J, and Nijkamp FP. Modulation of phagocytic cell function. Vet Res Commun 10: 165-188, 1986.
168. Henriksen AH, Sue-Chu M, Lingaas HT, Langhammer A, and Bjermer L. Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness. Eur Respir J 13: 301-306, 1999.
169. ω-hydroxy-D,L-indospicine, effects on L-arginine utilization by nitric oxide synthase. Br J Pharmacol 121: 395-400, 1997.
170. Hibbs JB, Taintor RR, Vavrin Z, and Rachlin EM. Nitric oxide: a cytotoxic activated macrophages effector molecule. Biochem Biophys Res Commun 157: 87-94, 1988.
171. Higenbottam T, Pepke-Zaba J, Scott J, Woolman P, Coutts C, and Wallwork J. Inhaled "endothelium-derived relaxing factor" (EDRF) in primary pulmonary hypertension (Abstract). Am Rev Respir Dis 137: 107A, 1988.
172. Hill CS and Treisman R. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80: 199-211, 1995.
173. Hislop AA, Springall DR, Buttery LD, Pollock JS, and Haworth SG. Abundance of endothelial nitric oxide synthase in newborn intrapulmonary arteries. Arch Dis Child 73: F17-F21, 1995.
174. Hobbs AJ and Ignarro LJ. The nitric oxide-cyclic GMP signal transduction system. In: Nitric Oxide and the Lung, edited by W. M. Zapol and K. D. Bloch. New York: Dekker, 1997, p. 1-57.
175. Hoffmann B and Fischer A. Nitric oxide synthase in neurons and nerve fibers of lower airways and in vagal sensory ganglia of man: correlation with neuropeptides. Am J Respir Crit Care Med 154: 209-216, 1996.
176. Hoffman J, Haendeler J, Zeiher AM, and Dimmeler S. TNF-α and oxLDL induce a denitrosylation of proteins in endothelial cells. J Biol Chem 276: 41383-41387, 2001.
177. Högman M, Frostell C, Arnberg H, and Hedenstierna G. Inhalation of nitric oxide modulates methacholine-induced broncho-constriction in the rabbit. Eur Respir J 6: 177-180, 1993.
178. Högman M, Frostell C, Hedenström H, and Hedenstierna G. Inhalation of nitric oxide modulates adult human bronchial tone. Am Rev Respir Dis 148: 1474-1478, 1993.
179. Howard M, Fischer H, Roux J, Santos BC, Gullans SR, Yancey PH, and Welch WJ. Mammalian osmolytes and S-nitrosoglutathione promote ΔF508 CFTR protein maturation and function. J Biol Chem 278: 35159-35167, 2003.
180. Huang FP, Niedbala W, Wei XQ, Xu D, Feng GJ, Robinson JH, Lam C, and Liew FY. Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. Eur J Immunol 28: 4062-4070, 1998.
181. Hugod C. Effect of exposure to 43 ppm nitric oxide and 3.6 ppm nitrogen dioxide on rabbit lung. Int Arch Occup Environ Health 42: 159-167, 1979.
182. Huie RE and Padmaja S. The reaction of NO with superoxide. Free Radical Res Commun 18: 195-199, 1993.
183. + T cells in the antitumor immune response. J Exp Med 188: 2357-2368, 1998.
184. Hunt J, Erwin E, Palmer L, Vaughan J, Malhotra N, Platts-Mills TAE, and Gaston B. Expression and activity of pH-regulatory glutaminase in the human airway epithelium. Am J Respir Crit Care Med 165: 101-107, 2002.
185. Hunt J, Fang K, Malik R, Snyder A, Malhotra N, Platts-Mills TA, and Gaston B. Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med 161: 694-699, 2000.
186. Hunt J and Gaston B. Airway nitrogen oxide measurements in asthma and other pediatric respiratory diseases. J Pediatr 137: 14-20, 2000.
187. Hyde RW, Geigel EJ, Olszowka AJ, Krasneu JA, Forster RE, Utell MJ, and Frampton MW. Determination of production of nitric oxide by lower airways of humans: theory. J Appl Physiol 82: 1290-1296, 1997.
188. Ichinose F, Adrie C, Hurford WE, and Zapol WM. Prolonged pulmonary vasodilator action of inhaled nitric oxide by Zaprinast in awake lambs. J Appl Physiol 78: 1288-1295, 1995.
189. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 65: 1-21, 1989.
190. Ignarro LJ, Buga GM, Wood KD, Byrns RE, and Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265-9269, 1987.
191. Ignarro LJ and Kadowitz PJ. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu Rev Pharmacol Toxicol 25: 171-191, 1985.
192. Incalzi RA, Fuso L, De Rosa M, Di Napoli A, Basso S, Pagliari G, and Pistelli R. Electrocardiographic signs of chronic cor pulmonale: a negative prognostic finding in chronic obstructive pulmonary disease. Circulation 99: 1600-1605, 1999.
193. Inoue K, Akaike T, Iyamoto Y, Okamoto T, Sawa T, Otagiri M, Suzuki S, Yoshimura T, and Maeda H. Nitrosothiol formation catalyzed by ceruloplasmin. Implication for cytoprotective mechanism in vivo. J Biol Chem 274: 27069-27075, 1999.
194. 2 sensing. Science 292: 449-451, 2001.
195. Jia Y, Xu L, Heisler S, and Martin JG. Airways of a hyperresponsive rat strain show decreased relaxant responses to sodium nitroprusside. Am J Physiol Lung Cell Mol Physiol 269: L85-L91, 1995.
196. Jadeski LC, Hum KO, Chakraborty C, and Lala PK. Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Int J Cancer 86: 30-39, 2000.
197. Jain B, Rubinstein I, Robbins RA, Leise KL, and Sisson JH. Modulation of airway epithelial cell ciliary beat frequency by nitric oxide. Biochem Biophys Res Commun 191: 83-88, 1993.
198. Jain B, Rubistein I, Robbins RA, and Sisson JH. TNF-alpha and IL-1 beta upregulate nitric oxide-dependent ciliary motility in bovine airway epithelium. Am J Physiol Lung Cell Mol Physiol 268: L911-L917, 1995.
199. Jansen A, Drazen J, Osborne JA, Brown R, Loscalzo J, and Stamler JS. The relaxant properties in guinea pig airways of S-nitrothiols. J Pharmacol Exp Ther 261: 154-160, 1992.
200. +. Am J Physiol Lung Cell Mol Physiol 278: L899-L905, 2000.
201. Janssens SP, Bloch KD, Nong Z, Gerard RD, Zoldhelyi P, and Collen D. Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats. J Clin Invest 98: 317-324, 1996.
202. Janssens SP, Shimouchi A, Qertermous T, Bloch DB, and Bloch KD. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 267: 14519-14522, 1992.
203. Jatakanon A, Kharitonov SA, Lim S, and Barnes PJ. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma. Thorax 54: 108-114, 1999.
204. Jatakanon A, Lim S, Kharitonov SA, and Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 53: 91-95, 1998.
205. Jones SA, O'Donnell VB, Wood JD, Broughton JP, Hughes EJ, and Jones OTG. Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol Heart Circ Physiol 271: H1626-H1634, 1996.
206. Jorens PG, Van Overveld FJ, Bult H, Veremire PA, and Herman AG. L-Arginine dependent production of nitrogen oxides by rat pulmonary macrophages. Eur J Pharmacol 200: 205-209, 1991.
207. Jorens PG, Van Overveld FJ, Bult H, Vermeire PA, and Herman AG. Muramyldipeptide and granulocyte-macrophage colony-stimulating factor enhance interferon-γ-induced nitric oxide production by rat alveolar macrophages. Agents Actions 38: 100-105, 1993.
208. Jorens PG, Van Overveld FJ, Vermeire PA, Bult H, and Herman AG. Synergism between interleukin-1β and interferon-γ, an inducer of nitric oxide synthase, in rat lung fibroblasts. Eur J Pharmacol 224: 7-12, 1992.
209. Jorens PG, Vermeire PA, and Herman AG. L-Arginine-dependent nitric oxide synthase: a new metabolic pathway in the lung and airways. Eur Respir J 6: 258-266, 1993.
210. Kacmarek RM, Ripple R, Cockrill BA, Block KJ, Zapol WM, and Johnson DC. Inhaled nitric oxide. A bronchodilator in mild asthmatics with methacholine-induced bronchospasm. Am J Respir Crit Care Med 153: 128-135, 1996.
211. Kageyama N, Miura M, Ichinose M, Tomaki M, Ishikawa J, Ohuchi Y, Endoh N, and Shirato K. Role of endogenous nitric oxide in airway microvascular leakage induced by inflammatory mediators. Eur Respir J 10: 13-19, 1997.
212. Kaisers U, Busch T, Deja M, Donaubauer B, and Falke KJ. Selective pulmonary vasodilation in acute respiratory distress syndrome. Crit Care Med 31 Suppl: S337-S347, 2003.
213. Kannan MS and Johnson DE. Modulation of nitric oxide-dependent relaxation of pig tracheal smooth muscle by inhibitors of guanylyl cyclase and calcium activated potassium channels. Life Sci 56: 2229-2238, 1995.
214. Kannan MS, Prakash YS, Johnson DE, and Sieck GC. Nitric oxide inhibits calcium release from sarcoplasmic reticulum of porcine tracheal smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 272: L1-L7, 1997.
215. Karadag B, James AJ, Gultekin E, Wilson NM, and Bush A. Nasal and lower airway level of nitric oxide in children with primary ciliary diskinesia. Eur Respir J 13: 1402-1405, 1999.
216. Karupiah G, Xie Q, Buller RML, Nathan CF, Duarte C, and MacMicking JD. Inhibition of viral replication by interferon-gamma induced nitric oxide synthase. Science 261: 1445-1448, 1993.
217. Katayama Y, Higenbottam TW, Diaz de Atauri MJ, Cremona G, Akamine S, Barbera JA, and Rodriguez-Roisin R. Inhaled nitric oxide and arterial oxygen tension in patients with chronic pulmonary disease and severe pulmonary hypertension. Thorax 52: 120-124, 1997.
218. Kawai N, Bloch DB, Filippov G, Rabkina D, Suen HC, Losty PD, Janssens SP, Zapol WM, de la Monte S, and Bloch KD. Constitutive endothelial nitric oxide synthase gene expresssion is regulated during lung development. Am J Physiol Lung Cell Mol Physiol 268: L589-L595, 1995.
219. Kawamoto H, Takumida M, Takeno S, Watanabe H, Fukushima N, and Yajin K. Localization of nitric oxide synthase in human nasal mucosa with nasal allergy. Acta Otolaryngol 539: 65-70, 1998.
220. Kawamoto S, Amaya Y, Murakami K, Tokunaga F, Iwanaga S, Kobayashi K, Saheki T, Kimura S, and Mori M. Complete nucleotide sequence of cDNA and deduced amino acid sequence of rat liver arginase. J Biol Chem 262: 6280-6283, 1987.
221. Keeble JE and Moore PK. Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs. Br J Pharmacol 137: 295-310, 2002.
222. Kelm M. NO metabolism and breakdown. Biochim Biophys Acta 1411: 273-289, 1999.
223. Kelm M and Schrader J. Control of coronary vascular tone by nitric oxide. Circ Res 66: 1561-1575, 1990.
224. Kennedy T, Summer WR, Sylvester J, and Robertson D. Airway response to sublingual nitroglycerin in acute asthma. JAMA 246: 145-147, 1981.
225. Kesler BS, Mazzone SB, and Canning BJ. Nitric oxide-dependent modulation of smooth muscle tone by airway parasympathetic nerves. Am J Respir Crit Care Med 165: 481-488, 2002.
226. Kettle AJ, van Dalen CJ, and Winterbourn CC. Peroxynitrite and myeloperoxidase leave the same footprint in protein nitration. Redox Rep 3: 257-258, 1997.
227. Kharitonov S, Alving K, and Barnes PJ. Exhaled and nasal nitric oxide measurements: recommendations. Eur Respir J 10: 1683-1693, 1997.
228. Kharitonov SA, Barnes PJ, and O'Connor BJ. Reduction in exhaled nitric oxide after a single dose of nebulized budesonide in patients with asthma (Abstract). Am J Respir Crit Care Med 153: A799, 1996.
229. Kharitonov SA, Chung FK, Evans DJ, O'Connor BJ, and Barnes PJ. The elevated level of exhaled nitric oxide in asthmatic patients is mainly derived from the lower respiratory tract. Am J Respir Crit Care Med 153: 1773-1780, 1996.
230. Kharitonov SA, Lubec G, Lubec B, Hjelm M, and Barnes PJ. L-Arginine increases exhaled nitric oxide in normal human subjects. Clin Sci 88: 135-139, 1995.
231. Kharitonov SA, O'Connor BJ, Evans DJ, and Barnes PJ. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med 151: 1894-1899, 1995.
232. Kharitonov SA, Robbins RA, Yates D, Keatings V, and Barnes PJ. Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med 152: 609-612, 1995.
233. Kharitonov SA, Wells AU, O'Connor BJ, Cole PJ, Hansell DM, Logan-Sinclair RB, and Barnes PJ. Elevated levels of exhaled nitric oxide in bronchiectasis. Am J Respir Crit Care Med 151: 1889-1893, 1995.
234. Kharitonov SA, Yates DH, and Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 153: 454-457, 1996.
235. Kharitonov SA, Yates DH, Chung KF, and Barnes PJ. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J 9: 196-201, 1996.
236. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, and Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343: 133-135, 1994.
237. Kinnula VL, Yankaskas JR, Chang L, Virtanen I, Linnala A, Kang BH, and Crapo JD. Primary and immortalized (BEAS 2B) human bronchial epithelial cells have significant antioxidative capacity in vitro. Am J Respir Cell Mol Biol 11: 568-576, 1994.
238. Kinsella JP, Neish SR, Shaffer E, and Abman SH. Low dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340: 819-820, 1992.
239. Kirsch EA, Yuhanna IS, Chen Z, German Z, Sherman TS, and Shaul PW. Estrogen acutely stimulates endothelial nitric oxide synthase in H441 human airway epithelial cells. Am J Respir Cell Mol Biol 20: 658-666, 1999.
240. Klebanoff SJ. A peroxidase-mediated antimicrobial system in leukocytes. J Clin Invest 46: 1078, 1967.
241. Knowles RG, Merrett M, Salter M, and Moncada S. Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in rat. Biochem J 270: 833-836, 1990.
242. Kobzik L, Bredt DS, Lowenstein CJ, Drazen J, Gaston B, Sugarbaker D, and Stamler JS. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol 9: 371-377, 1993.
243. Kong L, Dunn GD, Keefer LK, and Korthuis RJ. Nitric oxide reduces tumor cell adhesion to isolated rat postcapillary venules. Clin Exp Metastasis 14: 335-343, 1996.
244. Kornau HC, Schenker LT, Kennedy MB, and Seeburg PH. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 269: 1737-1740, 1995.
245. Kostikas K, Papatheodorou G, Ganas K, Psathakis K, Panagou P, and Loukides S. pH in expired breath condensate of patients with inflammatory airway diseases. Am JRespir Crit Care Med 165: 1364-1370, 2002.
246. Krishna MT, Chauhan AJ, Frew AJ, and Holgate ST. Toxicological mechanisms underlying oxidant pollutant-induced airway injury. Rev Environ Health 13: 59-71, 1998.
247. Kubes P. Nitric oxide and microvascular permeability: a continuing dilemma. Eur Respir J 10: 4-5, 1997.
248. Kubes P, Suzuki M, and Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88: 4651-4655, 1991.
249. Kummer W, Fischer A, Kurkowski R, and Heym C. The sensory and sympathetic innervation of guinea-pig lung and trachea as studied by retrograde neuronal tracing and double-labelling immunohistochemistry. Neuroscience 49: 715-737, 1992.
250. Kummer W, Fischer A, Mundel P, Mayer B, Hora B, and Philippin B. Nitric oxide synthase in VIP-containing vasodilator nerve fibres in the guinea pig. Neuro Rep 3: 653-655, 1992.
251. Kwon NS, Stuehr DJ, and Nathan CF. Inhibition of tumor cell ribonucleotide reductase by macrophage derived nitric oxide. J Exp Med 174: 761-768, 1991.
252. Lamas S and Michel T. Molecular biological features of nitric oxide synthase isoforms. In: Nitric Oxide and the Lung, edited by W. M. Zapol and K. D. Bloch. New York: Dekker, 1997, p. 59-73.
253. Lee YC, Cheon KT, Lee HB, Kim W, Rhee YK, and Kim DS. Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with asthma. Allergy 55: 959-963, 2000.
254. Lei Y-H, Barnes PJ, and Rogers DF. Regulation of NANC neural bronchoconstriction in vivo in the guinea-pig: involvement of nitric oxide, vasoactive intestinal peptide and soluble guanylyl cyclase. Br J Pharmacol 108: 228-235, 1993.
255. Lehtimaki L, Kankaanranta H, Saarlelainen S, Hahtola P, Jarvenpan R, Koivula T, Turjanman V, and Moilanen E. Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation. Am J Respir Crit Care Med 163: 1557-1561, 2001.
256. Lewis RS and Deen WM. Kinetics of the reaction of nitric oxide with oxygen in aqueous solutions. Chem Res Toxicol 7: 568-574, 1994.
257. Lewis SJ, Bates JN, and Robertson TP. Are S-nitrosothiols EDRFS in the pulmonary circulation? (Abstract). Am JRespir Crit Care Med 165: A576, 2002.
258. Li CG and Rand MJ. Evidence that part of the NANC relaxant response of guinea pig trachea to electrical field stimulation is mediated by nitric oxide. Br J Pharmacol 102: 91-94, 1991.
259. Lilly CM, Stamler JS, Gaston B, Loscalzo J, and Drazen JM. Modulation of vasoactive intestinal peptide pulmonary relaxation by NO in tracheally superfused guinea pig lungs. Am J Physiol Lung Cell Mol Physiol 265: L410-L415, 1993.
260. Lim S, Jatakanon A, John M, Gilbey T, O'Connor BJ, and Barnes PJ. Effect of inhaled budesonide on lung function and airway inflammation. Am J Respir Crit Care Med 159: 22-30, 1999.
261. Lipton A, Johnson M, MacDonald T, Lieberman M, Gozal D, and Gaston B. S-Nitrosothiols signal the ventilatory response to hypoxia. Nature 413: 171-174, 2001.
262. Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HS, Sucher NJ, Loscalzo J, Singel DJ, and Stamler JS. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364: 626-632, 1993.
263. Liu CY, Wang CH, Chen TC, Lin HC, Yu CT, and Kuo HP. Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer. BrJ Cancer 78: 534-541, 1998.
264. Liu L, Hausladen A, Zeng M, Que L, Heitman J, and Stamler J. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature 410: 490-494, 2001.
265. Liu S, Adcock IM, Old RW, Barnes PJ, and Evans TW. Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. Biochem Biophys Res Commun 196: 1208-1213, 1993.
266. Liu X, Miller MJ, Joshi MS, Sadowska-Krowicka H, Clark DA, and Lancaster JR. Diffusion-limited reaction of free nitric oxide with erythrocytes. J Biol Chem 273: 18709-18713, 1998.
267. Loesch A and Burnstock G. Electroimmunocytochemical localization of endothelial and neuronal isoforms of nitric oxide synthase in rat cerebral basilary artery. Acta Neurobiol Exp 55: 45, 1995.
268. Loesch A and Burnstock G. Ultrastructural localization of nitric oxide synthase and endothelin in rat pulmonary artery and vein during postnatal development and ageing. Cell Tissue Res 283: 355-365, 1996.
269. Loukides S, Kharitonov SA, Wodehouse T, Cole PJ, and Barnes PJ. Effect of L-arginine on mucociliary function in primary ciliary diskinesia. Lancet 352: 371-372, 1998.
270. Lowestein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW, and Murphy WJ. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci USA 90: 9730-9734, 1993.
271. Luhrs H, Papadopoulos T, Schmidt HH, and Menzel T. Type I nitric oxide synthase in the human lung is predominantly expressed in capillary endothelial cells. Respir Physiol 129: 367-374, 2002.
272. Lyons CR. Emerging roles of nitric oxide in inflammation. Hosp Pract 31: 69-73, 77-80, 85-86, 1996.
273. Lyons CR, Orloff GJ, and Gunningham JM. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem 267: 6370-6374, 1992.
274. Mackay TW, Fitzpatrick MF, and Douglas NJ. Non-adrenergic, non-cholinergic nervous system and overnight airway caliber in asthmatic and normal subjects. Lancet 338: 1289-1292, 1991.
275. Malerba M, Clini E, Cremona G, Radaeli A, Bianchi L, Corda L, Pini L, Ricciardolo F, Grassi V, and Ambrosino N. Exhaled nitric oxide in patients with PiZZ phenotype-related al-anti-trypsin deficiency. Respir Med 95: 520-525, 2001.
276. Malmström RE, Törnberg DC, Settergren G, Liska G, Angdin M, Lundberg JO, and Weitzberg E. Endogenous nitric oxide release by vasoactive drugs monitored in exhaled air. Am J Respir Crit Care Med 168: 114-120, 2003.
277. Mannick J, Hausladen A, Liu L, Hess D, Zeng M, Miao Q, Kane L, Gow A, and Stamler J. Fas-induced capase denitrosylation. Science 284: 651-654, 1999.
278. Mannick J, Schonhoff C, Papeta N, Ghafourifar P, Szibor M, Fang K, and Gaston B. S-nitrosylation of mitochondrial caspases. J Cell Biol 154: 1111-1116, 2001.
279. Marshall C, Mamary AJ, Verhoeven AJ, and Marshall BE. Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction. Am J Respir Cell Mol Biol 15: 633-644,1996.
280. Marshall H and Stamler J. Inhibition of NF-kappa-B by S-nitrosylation. Biochemistry 40: 1688-1693, 2001.
281. Massaro AF, Gaston B, Kita D, Fanta C, Stamler JS, and Drazen JM. Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med 152: 800-803, 1995.
282. Massaro AF, Mehta S, Lilly CM, Kobzik L, Reilly JJ, and Drazen JM. Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am J Respir Crit Care Med 153: 1510-1514, 1996.
283. Mattes J, Storm van's GK, Reining U, Alving K, Ihorst G, Henschen M, and Kuehr J. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma. Eur Respir J 159: 1434-1438, 1999.
284. Maziak W, Loukides S, Culpitt S, Sullivan P, Kharitonov SA, and Barnes PJ. Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157: 998-1002, 1998.
285. Megson IL and Webb DJ. Nitric oxide donor drugs: current status and future trends. Exp Opin Invest Drugs 11: 587-601, 2002.
286. Mehta S, Lilly CM, Rollenhagen JE, Haley KJ, Asano K, and Drazen J. Acute and chronic effects of allergic airway inflammation on pulmonary nitric oxide production. Am J Physiol Lung Cell Mol Physiol 272: L124-L131, 1997.
287. Meßmer U, Reed J, and Brune B. Bcl-2 protects macrophages from nitric oxide-induced apoptosis. J Biol Chem 271: 20192-20197, 1996.
288. Meurs H, Hamer MAM, Pethe S, Vadon-Le Goff S, Boucher J-L, and Zaagsma J. Modulation of cholinergic airway reactivity and nitric oxide production by endogenous arginase activity. Br J Pharmacol 130: 1793-1798, 2000.
289. Meurs H, Maarsingh H, and Zaagsma J. Arginase and asthma: novel insights into nitric oxide homeostasis and airway responsiveness. Trends Pharmacol Sci 24: 450-455, 2003.
290. Meurs H, McKay S, Maarsingh H, Hamer MA, Macic L, Molendijk N, and Zaagsma J. Increased arginase activity underlies allergen-induced deficiency of cNOS-derived nitric oxide and airway hyperresponsiveness. Br J Pharmacol 136: 391-398, 2002.
291. Meurs H, Schuurman Duyvendak M, and Zaagsma J. Deficiency of nitric oxide in polycation-induced airway hyperreactivity. Br J Pharmacol 126: 559-562, 1999.
292. Michel T and Feron O. Nitric oxide synthases: which, where, how, and why? J Clin Invest 100: 2146-2152, 1997.
293. Miller WC and Shultz TF. Failure of nitroglycerin as a bronchodilator. Am Rev Respir Dis 120: 471, 1979.
294. Mills CD, Kincaid K, Alt JM, Hellman MJ, and Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 164: 6166-6173, 2000.
295. Miura M, Ichinose M, Kageyama N, Tomaki M, Takahashi T, Ishikawa J, Ohuchi Y, Oyake T, Endoh N, and Shirato K. Endogenous nitric oxide modifies antigen-induced microvascular leakage in sensitized guinea pig airways. J Allergy Clin Immunol 98: 144-151, 1996.
296. Miura M, Yamauchi H, Ichinose M, Ohuchi Y, Kageyama N, Tomaki M, Endoh N, and Shirato K. Impairment of neural nitric oxide-mediated relaxation after antigen exposure in guinea pig airways in vitro. Am J Respir Crit Care Med 156: 217-222, 1997.
297. Modolell M, Corraliza IM, Link F, Soler G, and Eichmann K. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur J Immunol 25: 1101-1104, 1995.
298. Moncada S and Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012, 1993.
299. Moncada S, Palmer RMJ, and Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
300. Moodley YP, Chetty R, and Lalloo UG. Nitric oxide levels in exhaled air and inducible nitric oxide synthase immunolocalization in pulmonary sarcoidosis. Eur Respir J 14: 22-827, 1999.
301. Mori M and Gotoh T. Regulation of nitric oxide production by arginine metabolic enzymes. Biochem Biophys Res Commun 275: 715-719, 2000.
302. Morris SM Jr, Bhamidipati D, and Kepka-Lenhart D. Human type II arginase: sequence analysis and tissue-specific expression. Gene 193: 157-161, 1997.
303. Morris SM and Billiar TR. New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol Endocrinol Metab 266: E829-E839, 1994.
304. Morris SM Jr, Kepka-Lenhart D, and Chen LC. Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells. Am J Physiol Endocrinol Metab 275: E740-E747, 1998.
305. Mosmann TR and Coffman RI. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 145-173, 1989.
306. Moya MP, Gow AJ, Califf RM, Goldberg RN, and Stamler JS. Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newborn. Lancet 360: 2076-2077, 2002.
307. Moya MP, Gow AJ, McMahon TJ, Toone EJ, Cheifetz IM, Goldberg RN, and Stamler JS. S-nitrosothiol repletion by an inhaled gas regulates pulmonary function. Proc Natl Acad Sci USA 98: 5792-5797, 2001.
308. Muijsers RBR, Folkerts G, Henricks PAJ, Sadeghi-Hashjin G, and Nijkamp FP. Peroxynitrite: a two faced metabolite of nitric oxide. Life Sci 60: 1833-1845, 1997.
309. Muijsers RBR, Ten Hacken NHT, Van Ark I, Folkerts G, Nijkamp FP, and Postma DS. L-Arginine is not the limiting factor for nitric oxide synthesis by human alveolar macrophages in vitro. Eur Respir J 18: 667-671, 2001.
310. Murphy MP. Nitric oxide and cell death. Biochim Biophys Acta 1411: 401-414, 1999.
311. Nabeyrat E, Jones GE, Fenwick PS, Barnes PJ, and Donnelly LE. Mitogen-activated protein kinases mediate peroxynitrite-induced cell death in human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 284: L1112-L1120, 2003.
312. Nagaki M, Shimura MN, Irokawa T, Sasaki T, and Shirato K. Nitric oxide regulation of glycoconjugate secretion from feline and human airways in vitro. Respir Physiol 102: 89-95, 1995.
313. Nelin LD, Krenz GS, Chicoine LG, Dawson CA, and Schapira RM. L-Arginine uptake and metabolism following in vivo silica exposure in rat lungs. Am J Respir Cell Mol Biol 26: 348-355, 2002.
314. Nijkamp FP and Folkerts G. Nitric oxide and bronchial reactivity. Clin Exp Allergy 24: 905-914, 1994.
315. Nijkamp FP, van der Linde HJ, and Folkerts G. Nitric oxide synthesis inhibitors induce airway hyperresponsiveness in the guinea pig in vivo and in vitro. Am Rev Respir Dis 148: 727-734, 1993.
316. Ninomiya H, Uchida Y, Endo T, Ohtsuka M, Nomura A, Saotome M, and Hasegawa S. The effects of calcitonin gene-related peptide on tracheal smooth muscle of guinea-pigs in vitro. Br J Pharmacol 119: 1341-1346, 1996.
317. Norman V and Keith CM. Nitrogen oxides in tobacco smoke. Nature 205: 915-916, 1965.
318. Ochoa JB, Udekwu AO, Billiar TR, Curran RD, Cerra FB, Simmons RL, and Peitzman AB. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 214: 621-626, 1991.
319. Oda H, Nogami H, Kusumoto S, Nakajima T, Kurata A, and Imai K. Long-term exposure to nitric oxide in mice. J Jpn Soc Air PoUut 11: 150-160, 1976.
320. O'Donnell VB, Eiserich JP, Bloodsworth A, Chumley PH, Kirk M, Barnes S, Darley-Usmar VM, and Freeman BA. Nitration of unsaturated fatty acids by nitric oxide-derived reactive species. Methods Enzymol 301: 454-470, 1999.
321. O'Garra A and Arai N. The molecular basis of T helper I1 and T helper 2 cell differentiation. Trends Cell Biol 10: 542-550, 2000.
322. Ohshima H, Celan I, Chazotte L, Pignatelli B, and Mower HF. Analysis of 3-nitrotyrosine in biological fluids and protein hydrolyzates by high-performance liquid chromatography using a post-separation, on-line reduction column and electrochemical detection: results with various nitrating agents. Nitric Oxide 3: 132-141, 1999.
323. Ohta H, Bates J, Lewis S, and Talman W. Actions of S-nitroso-cysteine in the nucleus tractus solitarii are unrelated to release of nitric oxide. Brain Res 746: 98-104, 1997.
324. Okamoto T, Valacchi G, Kishorchandra G, Takaaki A, and Van der Vliet A. S-nitrosothiols inhibit cytokine-mediated induction of matrix metalloproteinase-9 in airway epithelial cells. Am J Respir Cell Mol Biol 27: 463-473, 2002.
325. Okayama M, Sasaki H, and Takishima T. Bronchodilator effect of sublingual isosorbide dinitrate in asthma. Eur J Clin Pharmacol 26: 151-155, 1984.
326. Olry R, Mayer B and Kummer W. Nitric oxide synthase in the pre- and postganglionic axis of the sympathetic nervous system in the guinea pig. In: Biology of Nitric Oxide. Part 2, edited by S. Moncada, M. Feelisch, R. Busse, and E. A. Higgs. London: Portland, 1994, p. 330-334.
327. Ozaki M, Kawashima S, Yamashita T, Ohashi Y, Rikitake Y, Inoue N, Hirata KI, Hayashi Y, Itoh H, and Yokoyama M. Reduced hypoxic pulmonary vascular remodeling by nitric oxide from the endothelium. Hypertension 37: 322-327, 2001.
328. Pabelick CM, Warner DO, Perkins WJ, and Jones KA. S-nitrosoglutathione- induced decrease in calcium sensitivity of airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 278: L521-L527, 2000.
329. Packer MA and Murphy MP. Peroxynitrite formed by simultaneous nitric oxide and superoxide generation causes cyclosporin-A-sensitive mitochondrial calcium efflux and depolarisation. Eur J Biochem 234: 231-239, 1995.
330. Palmer LA, Gaston B, and Johns RA. Normoxic stabilization of hypoxia inducible factor I expression and activity: redox-dependent effect of nitrogen oxides. Mol Pharmacol 58: 1197-1203, 2000.
331. Palmer RM, Ferrige AG, and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987.
332. Paredi P, Kharitonov SA, Loukides S, Pantelidis P, Du Bois RM, and Barnes PJ. Exhaled nitric oxide is increased in active fibrosing alveolitis. Chest 115: 1352-1356, 1999.
333. Parker TA, le Cras TD, Kinsella JP, and Abman SH. Developmental changes in endothelial nitric oxide synthase expression and activity in ovine fetal lung. Am J Physiol Lung Cell Mol Physiol 78: L202-L208, 2000.
334. Patel. HJ, Belvisi MG, Donnelly LE, Yacoub MH, Chung KF, and Mitchell JA. Constitutive expressions of type I NOS in human airway smooth muscle cells: evidence for an antiproliferative role. FASEB J 13: 1810-1816, 1999.
335. Pawloski JR, Hess DT, and Stamler JS. Export by red blood cells of nitric oxide bioactivity. Nature 409: 622-626, 2001.
336. Payne DNR, Adcock IM, Wilson NM, Oates T, Scallan M, and Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med 164: 1376-1381, 2001.
337. Pechkovsky DV, Zissel G, Goldmann T, Einhaus M, Taube C, Magnussen H, Schlaak M, and Muller-Quernheim J. Pattern of NOS2 and NOS3 mRNA expression in human A549 cells and primary cultured AEC II. Am J Physiol Lung Cell Mol Physiol 282: L684-L692, 2002.
338. Pechkovsky DV, Zissel G, Stamme C, Goldmann T, Ari Jaffe H, Einhaus M, Taube C, Magnussen H, Schlaak M, and Muller-Quernheim J. Human alveolar epithelial cells induce nitric oxide synthase-2 expression in alveolar macrophages. Eur Respir J 19: 672-683, 2002.
339. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, and Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet 338: 1173-1174, 1991.
340. Perez-Mato I, Castro C, Ruiz FA, Corrales FJ, and Mato J-M. Methionine adenosyltransferase S-nitrosylation is regulated by the basic and acidic amino acids surrounding the target thiol. J Biol Chem 274: 17075-17079, 1999.
341. Perkins WJ, Pabelick C, Warner DO, and Jones KA. cGMP-independent mechanism of airway smooth muscle relaxation induced by S-nitrosoglutathione. Am J Physiol Cell Physiol 275: C468-C474, 1998.
342. Persson MG, Friberg SG, Gustafsson LE, and Hedqvist P. The promotion of patent airways and inhibition of antigen-induced bronchial obstruction by endogenous nitric oxide. Br J Pharmacol 116: 2957-2962, 1995.
343. Persson MG, Friberg SG, Hedqvist P, and Gustafsson LE. Endogenous nitric oxide counteracts antigen-induced bronchoconstriction. Eur J Pharmacol 249: R7-R8, 1993.
344. Persson MG, Gustafsson LE, Wiklund NP, Moncada S, and Hedqvist P. Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor response in vivo. Acta Physiol Scand 140: 449-457, 1990.
345. Persson MG, Zetterstrom O, Agrenius V, Ihre E, and Gustafsson LE. Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet 343: 146-147, 1994.
346. Phillips CR, Giraud GD, and Holden WE. Exhaled nitric oxide during exercise: site of release and modulation by ventilation and blood flow. J Appl Physiol 80: 1865-1871, 1996.
347. Phillips PG, Birnby LM, Narendran A, and Milonovich WL. Nitric oxide modulates capillary formation at the endothelial cell-tumor cell interface. Am J Physiol Lung Cell Mol Physiol 281: L278-L290, 2001.
348. Pietarinen-Runtti P, Lakari E, Raivio KO, and Kinnula VL. Expression of antioxidant enzymes in human inflammatory cells. Am J Physiol Cell Physiol 279: C118-C125, 2000.
349. Pison U, Lopez FA, Heidelmeyer CF, Rossaint R, and Falke K. Inhaled nitric oxide selectively reverses hypoxic pulmonary vasoconstriction without impairing pulmonary gas exchange. J Appl Physiol 74: 7287-7292, 1993.
350. Pitt BR and St Croix CM. Complex regulation of iNOS in lung. Am J Respir Cell Mol Biol 26: 6-9, 2002.
351. Pryor WA and Squadrito GL. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol Lung Cell Mol Physiol 268: L699-L722, 1995.
352. Putensen C, Rasanen J, Lopez LA, and Downs JB. Continuous positive airway pressure modulates effect of inhaled nitric oxide on the ventilation-perfusion distributions in canine lung injury. Chest 106: 1563-1569, 1994.
353. Puybasset L, Stewart T, Rouby JJ, Cluzel P, Mourgeon E, Belin MF, Arthaud M, Landault C, and Viars P. Inhaled nitric oxide reverses the increase in pulmonary vascular resistance induced by permissive hypercapnia in patients with acute respiratory distress syndrome. Anesthesiology 80: 1254-1267, 1994.
354. Que LG, Kantrow SP, Jenkinson CP, Piantadosi CA, and Huang YC. Induction of arginase isoforms in the lung during hyperoxia. Am J Physiol Lung Cell Mol Physiol 275: L96-L102, 1998.
355. Radi R, Beckman JS, Bush KM, and Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 288: 481-487, 1991.
356. Radomski MW, Palmer RMJ, and Moncada S. An L-arginine: nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 87: 5193-5197, 1990.
357. Rafikova O, Rafikov R, and Nudler E. Catalysis of S-nitrosothiols formation by serum albumin: the mechanism and implication in vascular control. Proc Natl Acad Sci USA 99: 5913-5918, 2002.
358. Rapoport RM and Murad F. Agonist induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cyclic GMP. Circ Res 52: 352-357, 1983.
359. Ratjen F, Gartig S, Wiesemann HG, and Grasemann H. Effect of inhaled nitric oxide on pulmonary function in cystic fibrosis. Respir Med 93: 579-583, 1999.
360. Reiter CD, Teng RJ, and Beckman JS. Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite. J Biol Chem 275: 32460-32466, 2000.
361. Repine JE, Bast A, Lankhorst I, and Group TOSS. Oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 156: 341-357, 1997.
362. Ricciardolo FLM, Di Maria GU, Mistretta A, Sapienza MA, and Geppetti P. Impairment of bronchoprotection by nitric oxide in severe asthma. Lancet 350: 1297-1298, 1997.
363. Ricciardolo FLM, Di Stefano A, van Schadewijk A, Rabe KF, Rossi A, and Sterk PJ. Increased exhaled nitric oxide after allergen exposure is related to mucosal eosinophilic inflammation in asthma (Abstract). Am J Respir Crit Care Med 165: A310, 2002.
364. Ricciardolo FLM, Geppetti P, Mistretta A, Nadel JA, Sapienza MA, Bellofiore S, and Di Maria GU. Randomized double-blind placebo-controlled study of the effect of inhibition of nitric oxide synthesis in bradykin-induced asthma. Lancet 348: 374-377, 1996.
365. Ricciardolo FLM, Nadel JA, Yoshihara S, and Geppetti P. Evidence for reduction of bradykinin-induced bronchoconstriction in guinea pigs by release of nitric oxide. Br J Pharmacol 113: 1147-1152, 1994.
366. Ricciardolo FLM, Rado V, Fabbri LM, Sterk PJ, Di Maria GU, and Geppetti P. Bronchoconstriction induced by citric acid inhalation: role of tachykinins, bradykinin and nitric oxide. Am J Respir Crit Care Med 159: 557-562, 1999.
367. Ricciardolo FLM, Steinhoff A, Amadesi S, Guerrini R, Tognetto M, Trevisani M, Creminon C, Bertrand C, Bunnett NW, Fabbri LM, Salvadori S, and Geppetti P. Presence and bronchomotor activity of protease activated receptor-2 (PAR-2) in guinea pig airways. Am J Respir Crit Care Med 161: 1672-1680, 2000.
368. Ricciardolo FLM, Timmers MC, Geppetti P, van Schadewijk WA, Sont J, de Gouw HWFM, van Krieken JHJM, Hiemstra PS, and Sterk PJ. Allergen-induced impairment of bronchoprotective nitric oxide synthesis in asthma. J Allergy Clin Immunol 108: 198-204, 2001.
369. Ricciardolo FLM, Trevisani M, Geppetti P, Nadel JA, Amadesi S, and Bertrand C. NKA-induced bronchoconstriction in vivo is reduced by nitric oxide release via septide-insensitive NK1 receptor activation. Br J Pharmacol 129: 915-920, 2000.
370. Ricciardolo FLM, Vergnani L, Wiegand S, Ricci F, Manzoli N, Fischer A, Amadesi S, Fellin R, and Geppetti P. Detection of bradykinin-induced nitric oxide release in the airways of guinea pigs by porphirinic microsensor. Am J Respir Cell Mol Biol 22: 97-104, 2000.
371. Riley MS, Porszasz J, Miranda J, Engelen MP, Brundage B, and Wasserman K. Exhaled nitric oxide during exercise in primary pulmonary hypertension and pulmonary fibrosis. Chest 111: 44-50, 1997.
372. Rimar S and Gillis CN. Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation 88: 2884-2887, 1993.
373. Robbins RA, Barnes PJ, Springall DR, Warren JB, Kwon OJ, Buttery LD, Wilson AJ, Geller DA, and Polak JM. Expression of inducible nitric oxide in human lung epithelial cells. Biochem Biophys Res Commun 203: 209-218, 1994.
374. Robbins RA, Springall DR, Warren JB, Know OJ, Buttery LDK, Wilson AJ, Adcock IM, Polak JM, and Barnes PJ. Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation. Biochem Biophys Res Commun 198: 1027-1033, 1994.
375. Roberts JD, Polander DM, Lang P, and Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340: 818-819, 1992.
376. Roger N, Barbera JA, Roca J, Rovira I, Gomez FP, and Rodriguez-Roisin R. Nitric oxide inhalation during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 156: 800-806, 1997.
377. Romagnani S. Human TH1 and TH2 subsets: doubt no more. Immunol Today 12: 256-257, 1991.
378. Romanska HM, Ikonen TS, Bishop AE, Morris RE, and Polak JM. Up-regulation of inducible nitric oxide synthase in fibroblasts parallels the onset and progression of fibrosis in an experimental model of post-transplant obliterative airway disease. J Pathol 191: 71-77, 2000.
379. Romanska HM, Polak JM, Coleman RA, James RS, Harmer DW, Allen JC, and Bishop AE. iNOS gene upregulation is associated with the early proliferative response of human lung fibroblasts to cytokine stimulation. J Pathol 197: 372-379, 2002.
380. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, and Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328: 399-405, 1993.
381. Ruggiero DA, Mtui K, Otake K, and Anwar M. Central and primary visceral afferents to nucleus tractus solotarii may generate nitric oxide synthase as a membrane-permeant neuronal messenger. J Comp Neurol 364: 51-67, 1996.
382. Rutgers SR, van der Mark TW, Coers W, Moshage H, Timens W, Kauffman HF, Koeter GH, and Postma DS. Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease. Thorax 54: 576-580, 1999.
383. Sadeghi-Hashjin G, Folkerts G, Henricks PAJ, Muijsers RBR, and Nijkamp FP. Peroxynitrite in airway diseases. Clin Exp Allergy 28: 1464-1473, 1998.
384. Sadeghi-Hashjin G, Folkerts G, Henricks PA, Van de Loo PG, Van der Linde HJ, Dik IE, and Nijkamp FP. Induction of guinea pig airway hyperresponsiveness by inactivation of guanylyl cyclase. Eur J Pharmacol 302: 109-115, 1996.
385. Saleh D, Ernst P, Lim S, Barnes PJ, and Giaid A. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J 12: 929-937, 1998.
386. Samb A, Pretolani M, Dinh-Xuan A-T, Ouksel H, Callebert J, Lisdero C, Aubier M, and Boczkowski J. Decreased pulmonary and tracheal smooth muscle expression and activity of type 1 nitric oxide synthase (nNOS) after ovalbumin immunization and multiple aerosol challenge in guinea pigs. Am J Respir Crit Care Med 164: 149-154, 2001.
387. Sapienza MA, Kharitonov SA, Horvath I, Chung KF, and Barnes PJ. Effect of inhaled L-arginine on exhaled nitric oxide in normal and asthmatic subjects. Thorax 53: 172-175, 1998.
388. Sasaki F, Parè P, Ernest D, Bai T, Verburg L, March R, and Baile E. Endogenous nitric oxide influences acetylcholine-induced bronchovascular dilation in sheep. J Appl Physiol 78: 539-545, 1995.
389. Saura M, Zaragoza C, McMillian A, Quick RA, Hohenadl C, Lowenstein JM, and Lowenstein CJ. An antiviral mechanism of nitric oxide: inhibition of a viral protease. Immunity 10: 21-28, 1999.
390. 2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 275: 21722-21729, 2000.
391. Schmidt HH, Hofmann H, Schindler U, Shutenko ZS, Cunningham DD, and Feelisch M. No NO from NO synthase. Proc Natl Acad Sci USA 93: 14492-14497, 1996.
392. Schuiling M, Meurs H, Zuidhof AB, Venema N, and Zaagsma J. Dual action of iNOS-derived nitric oxide in allergen-induced airway hyperreactivity in conscious, unrestrained guinea pigs. Am J Respir Crit Care Med 158: 1442-1449, 1998.
393. Schuiling M, Zuidhof AB, Bonouvrie MAA, Venema N, Zaagsma J, and Meurs H. Role of nitric oxide in the development and partial reversal of allergen-induced airway hyperreactivity in conscious, unrestrained guinea-pigs. Br J Pharmacol 123: 1450-1456, 1998.
394. Shaul PW. Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol 64: 749-774, 2002.
395. Shaul PW, Afshar S, Gibson LL, Sherman TS, Kerecman JD, Grubb PH, Yoder BA, and McCurnin DC. Developmental changes in nitric oxide synthase isoform expression and nitric oxide production in fetal baboon lung. Am J Physiol Lung Cell Mol Physiol 283: L1192-L1199, 2002.
396. Shaul P, North AJ, Wu LC, Wells LB, Brannon TS, Lau KS, Michel T, Margraf LR, and Star RA. Endothelial nitric oxide synthase is expressed in cultured human bronchiolar epithelium. J Clin Invest 94: 2231-2236, 1994.
397. Sherman TS, Chen Z, Yuhanna IS, Lau KS, Margraf LR, and Shaul PW. Nitric oxide synthase isoform expression in the developing lung epithelium. Am J Physiol Lung Cell Mol Physiol 276: L383-L390, 1999.
398. Shimosegawa T and Toyota T. NADPH-diaphorase activity as a marker for nitric oxide synthase in neurons of the guinea pig respiratory tract. Am J Respir Crit Care Med 150: 1402-1410, 1994.
399. Silkoff PE, Caramori M, Tremblay L, McClean P, Chaparro C, Kesten S, Hutcheon M, Slutsky AS, Zamel N, and Keshavjee S. Exhaled nitric oxide in human lung transplantation. A noninvasive marker of acute rejection. Am J Respir Crit Care Med 157: 1822-1828, 1998.
400. Silvestri M, Spallarossa D, Frangova Y, Battistini E, Fregonese B, and Rossi GA. Orally exhaled nitric oxide levels are related to the degree of blood eosinophilia in atopic children with mild-intermittent asthma. Eur Respir J 13: 321-326, 1999.
401. Sippel JM, Holden WE, Tilles SA, O'Hollaren M, Cook J, Thukkani N, Priest J, Nelson B, and Osborne M. Exhaled nitric oxide levels correlate with measures of disease control in asthma. J Allergy Clin Immunol 106: 645-650, 2000.
402. Snyder A, McPherson ME, Hunt JF, Johnson M, Stamler JS, and Gaston B. Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis. Am J Respir Crit Care Med 165: 1-5, 2002.
403. Stamler JS, Singel DJ, and Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 258: 1898-1902, 1992.
404. Stamler JS, Toone E, Lipton S, and Sucher N. (S)NO signals: translocation, regulation, and a consensus motif. Neuron 18: 691-696, 1997.
405. Sterk PJ, de Gouw HWFM, Ricciardolo FLM, and Rabe KF. Exhaled nitric oxide in COPD: glancing through a smoke screen. Thorax 54: 565-567, 1999.
406. Storm van 's Gravesande K, Wechsler ME, Grasemann H, Silverman ES, Le Lyle L, and Drazen JM. Association of mis-sense mutation in the NOS3 gene with exhaled nitric oxide levels. Am J Respir Crit Care Med 168: 228-231, 2003.
407. Stretton D. Nonadrenergic, noncholinergic neural control of the airways. Clin Exp Pharmacol Pathol 18: 675-684, 1991.
408. Su Y, Han W, Giraldo C, De Li Y, and Block ER. Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol 19: 819-825, 1998.
409. Sylvester JT and Permutt S. Exhaled NO: first, hold your breath. J Appl Physiol 91: 474-476, 2001.
410. Swislocki A, Eason T, and Kaysen GA. Oral administration of the nitric oxide biosynthesis inhibitor, N-nitro-L-arginine methyl ester (L-NAME), causes hypertension, but not glucose intolerance or insulin resistance, in rats. Am J Hypertens 8: 1009-1014, 1995.
411. Taylor DA, McGrath JL, O'Connor BJ, and Barnes PJ. Allergen-induced early and late asthmatic responses are not affected by inhibition of endogenous nitric oxide. Am J Respir Crit Care Med 158: 99-106, 1998.
412. Taylor DA, McGrath JL, Orr LM, Barnes PJ, and O'Connor BJ. Effect of endogenous nitric oxide inhibition on airway responsiveness to histamine and adenosine-5′-monophosphote in asthma. Thorax 53: 483-489, 1998.
413. Taylor-Robinson AW, Liew FY, Severn A, Xu D, McSorley SJ, Garside P, Padron J, and Phillips RS. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur J Immunol 24: 980-984, 1994.
414. Taylor-Robinson AW, Phillips RS, Severn A, Moncada S, and Liew FY. The role of TH1 and TH2 cells in a rodent malaria infection. Science 260: 1931-1934, 1993.
415. Ten Brocke R, Folkerts R, De Crom R, van Haperen R, Verwey V, Leusink-Muis T, van Ark I, De Clerck F, and Nijkamp F. Overexpression of eNOS suppresses asthmatic features in a mouse model of allergic asthma (Abstract). Eur Respir J 20: 28s, 2002.
416. Ten Broeke R, Folkerts G, Leusink-Muis T, Van Der Linde HJ, Villain M, Manion MK, De Clerck, F, Blalock JE, and Nijkamp FP. Calcium sensors as new therapeutic targets for airway hyperresponsiveness and asthma. FASEB J 15: 1831-1833, 2001.
417. Thomae KR, Geller DA, Billiar TR, Davies P, Pitt BR, Simmons RL, and Nakayama DK. Antisense oligodeoxynucleotide to inducible nitric oxide synthase muscle cells in culture. Surgery 114: 272-277, 1993.
418. 2. Proc Natl Acad Sci USA 98: 355-360, 2001.
419. Thomassen MJ, Buhrow LT, Connors MJ, Kaneko T, Erzurum SC, and Kavuru MS. Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages. Am J Respir Cell Mol Biol 17: 279-283, 1997.
420. Thompson D and Altiere R. Differential susceptibility of tracheal contraction to nonadrenergic noncholinergic relaxation. J Pharmacol Exp Ther 284: 19-24, 1998.
421. Torres G and Rivier C. Induction of c-f os in rat brain by acute cocaine and fenfluramine exposure: a comparison study. Brain Res 647: 1-9, 1994.
422. Toward TJ and Broadley KJ. Airway reactivity, inflammatory cell influx and nitric oxide in guinea-pig airways after lipopolysaccharide inhalation. Br J Pharmacol 131: 271-281, 2000.
423. Trifilieff A, Fujitani Y, Mentz F, Dugas B, Fuentes M, and Bertrand C. Inducible nitric oxide synthase inhibitors suppress airway inflammation in mice through down-regulation of chemokine expression. J Immunol 165: 1526-1533, 2000.
424. Tsoukias NM and George SC. A two-compartment model of pulmonary nitric oxide exchange dynamics. J Appl Physiol 85: 653-666, 1998.
425. G-nitroarginine inhibits non-adrenergic, non-cholinergic relaxations of guinea pig isolated tracheal smooth muscle. Br J Pharmacol 100: 663-664, 1990.
426. Tulic MK, Wale JL, Holt PG, and Sly PD. Differential effects of nitric oxide synthase inhibitors in an in vivo allergic rat model. Eur Respir J 161: 870-877, 2000.
427. Tzao C, Nickerson PA, Russell JA, Noble BK, and Steinhorn RH. Heterogeneous distribution of type I nitric oxide synthase in pulmonary vasculature of ovine fetus. Histochem Cell Biol 114: 421-430, 2000.
428. Uetani K, Thomassesen MJ, and Erzurum SC. Nitric oxide synthase 2 through an autocrine loop via respiratory epithelial cell-derived mediator. Am J Physiol Lung Cell Mol Physiol 280: L1179-L1188, 2001.
429. Uppu RM, Squadrito GL, and Pryor WA. Acceleration of peroxynitrite oxidations by carbon dioxide. Arch Biochem Biophys 327: 335-343, 1996.
430. Vallyathan V and Shi X. The role of oxygen free radicals in occupational and environmental lung diseases. Environ Health Perspect 105: 165-177, 1997.
431. Van der Vliet A, Eiserich JP, Shigenaga MK, and Cross CE. Reactive nitrogen species and tyrosine nitration in the respiratory tract: epiphenomena or a pathobiologic mechanism of disease? Am J Respir Crit Care Med 160: 1-9, 1999.
432. Van Rensen EL, Straathof KC, Veselic-Charvat MA, Zwinderman AH, Bel EH, and Sterk PJ. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma. Thorax 54: 403-408, 1999.
433. Vercelli D. Arginase: marker, effector, or candidate gene for asthma? J Clin Invest 111: 1815-1817, 2003.
434. Vockley JG, Jenkinson CP, Shukla H, Kern RM, Grody WW, and Cederbaum SD. Cloning and characterization of the human type II arginase gene. Genomics 38: 118-123, 1996.
435. Vonbank K, Ziesche R, Higenbottam TW, Stiebellehner L, Petkov V, Schenk P, Germann P, and Block LH. Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD. Thorax 58: 289-293, 2003.
436. Ward JK, Barnes PJ, Springall DR, Abelli L, Tadjkarimi S, Yacoub MH, Polak JM, and Belvisi MG. Distribution of human i-NANC bronchodilator and nitric oxide-immunoreactive nerves. Am J Respir Cell Mol Biol 13: 175-184, 1995.
437. Ward JK, Barnes PJ, Tadjkarimi S, Yacoub MH, and Belvisi MG. Evidence for the involvement of cGMP in neural bronchodilator responses in human trachea. J Physiol 483: 525-536, 1995.
438. Ward JK, Belvisi MG, Fox AJ, Miura M, Tadjkarimi, Yacoub MH, and Barnes PJ. Modulation of cholinergic neural bronchoconstriction by endogenous nitric oxide and vasoactive intestinal peptide in human airways in vitro. J Clin Invest 92: 736-742, 1993.
439. Warner RL, Paine R, Christensen PJ, Marletta MA, Richards MK, Wilcosen SE, and Ward PA. Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase. Am J Respir Cell Mol Biol 12: 649-661, 1995.
440. Watkins DN, Peroni DJ, Basclain KA, Garlepp MJ, and Thompson PJ. Expression and activity of nitric oxide synthases in human airway epithelium. Am J Respir Cell Mol Biol 16: 629-639, 1997.
441. Watson N, Maclagan J, and Barnes PJ. Vagal control of guinea pig tracheal smooth muscle: lack of involvement of VIP or nitric oxide. J Appl Physiol 74: 1964-1971, 1993.
442. Wechsler ME, Grasemann H, Deykin A, Silverman EK, Yandava CN, Israel E, Wand M, and Drazen JM. Exhaled nitric oxide in patients with asthma: association with NOS1 genotype. Am J Respir Crit Care Med 162: 2043-2047, 2000.
443. Weinberg JB. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review. Mol Med 4: 57-591, 1998.
444. White TA, Walseth TF, and Kannan MS. Nitric oxide inhibits ADP-ribosyl cyclase through a cGMP-independent pathway in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 283: L1065-L1071, 2002.
445. Widdicombe JG. Autonomic regulation, i-NANC/e-NANC. Am J Respir Crit Care Med 158: S171-S175, 1998.
446. Wiesinger H. Arginine metabolism and the synthesis of nitric oxide in the nervous system. Prog Neurobiol 64: 365-391, 2001.
447. Wihelm E, Battino R, and Wilcock RJ. Low-pressure solubility of gases in liquid water. Chem Rev 77: 229, 1977.
448. Wileman SM, Mann GE, and Baydoun AR. Induction of L-arginine transport and nitric oxide synthase in vascular smooth muscle cells: synergistic actions of pro-inflammatory cytokines and bacterial lipopolysaccharide. Br J Pharmacol 116: 3243-3250, 1995.
449. Williams MS, Noguchi S, Henkart PA, and Osawa Y. Nitric oxide synthase plays a signaling role in TCR-triggered apoptotic death. J Immunol 161: 6526-6531, 1998.
450. Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M, Dunams TM, Cebula AC, Koch Wh, Andrews AW, Allen JS, and Keefer LK. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254: 1001-1003, 1991.
451. Wink DA, Vodovotz Y, Laval J, and Laval F, Dewhirst MW, and Mitchell JB. The multifaceted roles of nitric oxide in cancer. Carcinogenesis 19: 711-721, 1998.
452. Wu G and Morris SM Jr. Arginine metabolism: nitric oxide and beyond. Biochem J 336: 1-17, 1998.
453. Wu W, Chen Y, and Hazen SL. Eosinophil peroxidase nitrates protein tyrosyl residues. Implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders. J Biol Chem 274: 25933-25944, 1999.
454. Wu W, Li Y, and Schinco FP. Expression of c-jun and neuronal nitric oxide synthase in rat spinal motoneurons following axonal injury. Neurosci Lett 179: 157-161, 1994.
455. Xie Q, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, and Nathan C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256: 225-228, 1992.
456. Xiong Y, Karupiah G, Hogan S, Foster PS, and Ramsay AJ. Inhibition of allergic airway inflammation in mice lacking nitric oxide synthase 2. J Immunol 162: 445-452, 1999.
457. Xue C, Botkin SJ, and Johns RA. Localization of endothelial NOS at the basal microtubule membrane in ciliated epithelium of rat lung. J Histochem Cytochem 44: 463-471, 1996.
458. Xue C, Rengasamy A, Le-Cras TD, Koberna PA, Dailey GC, and Johns RA. Distribution of NOS in hypoxic rat lung: upregulation of chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 267: L667-L678, 1994.
459. Xue C, Reynolds PR, and Johns RA. Developmental expression of NOS isoforms in fetal rat lung: implications for transitional circulation and puhnonary angiogenesis. Am J Physiol Lung Cell Mol Physiol 270: L88-L100, 1996.
460. + channels in porcine tracheal smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 270: L338-L345, 1996.
461. Yan ZQ, Hansson GK, Skoogh BE, and Lotvall JO. Induction of nitric oxide synthase in a model of allergic occupational asthma. Allergy 50: 760-764, 1995.
462. Yates DH, Kharitonov SA, Thomas PS, and Barnes PJ. Endogenous nitric oxide is decreased in asthmatic patients by an inhibitor of inducible nitric oxide synthase. Am J Respir Crit Care Med 154: 247-250, 1996.
463. Yeadon M and Price R. Induction of calcium-indepedent nitric oxide synthase by allergen challenge in sensitized rat lung in vivo. Br J Pharmacol 116: 2545-2546, 1995.
464. Yoshie Y and Ohshima H. Synergistic induction of DNA strand breakage by cigarette tar and nitric oxide. Carcinogenesis 18: 1359-1363, 1997.
465. Zaman K, McPherson M, Vaughan J, Hunt J, Mendes F, Gaston B, and Palmer L. S-Nitrosoglutathione increases cystic fibrosis transmembrane regulator maturation. Biochem Biophys Res Commun 284: 65-70, 2001.
466. Zaman K, Vaughan J, Hunt J, Palmer L, and Gaston B. Transcription factor SP1 is involved in the regulation of cystic fibrosis transmembrane conductance regulator by endogenous S-nitrosoglutathione (Abstract). Am J Respir Crit Care Med 165: A279, 2002.
467. Zhu W and Smart EJ. Caveolae, estrogen and nitric oxide. Trends Endocrinol Metab 14: 114-117, 2003.
468. Zimmerman N, King NE, Laporte J, Yang M, Mishra A, Pope SM, Muntel EE, Witte DP, Pegg AA, Foster PS, Hamid Q, and Rothenberg ME. Dissection of experimental asthma with DNA microarray analysis indentifies arginase in asthma pathogenesis. J Clin Invest 111: 1863-1874, 2003.
469. Zingarelli B, O'Connor M, Wong H, Salzman AL, and Szabo C. Peroxynitrite-mediated DNA strand breakage activates poly-adenosine diphosphate ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide. J Immunol 156: 350-358, 1996.
470. Zweier JL, Samouilov A, and Kuppusamy P. Non-enzymatic NO synthesis in biological systems. Biochim Biophys Acta 1411: 250-262, 1999.